Prevention of osteoporosis. Current recommendations

Area of Science:

• Gerontology
• Endocrinology
• Orthopedics

Background:

• Osteoporosis is a significant health concern, particularly in post-menopausal women, leading to fractures, morbidity, and high healthcare costs.
• The economic burden in the UK alone exceeds £500 million annually for treating osteoporosis-related fractures.
• Understanding the causes of osteoporosis allows for preventive strategies, especially for at-risk populations.

Purpose of the Study:

• To review current understanding and treatment of osteoporosis, focusing on prevention and management strategies.
• To evaluate the role of hormone replacement therapy (HRT) and alternative treatments for osteoporosis.
• To discuss the challenges in treating established osteoporosis and the need for confirmed fracture reduction data.

Main Methods:

• Literature review of osteoporosis research, focusing on prevention and treatment modalities.
• Analysis of existing data on hormone replacement therapy (HRT) efficacy and benefits.
• Exploration of emerging treatments targeting bone resorption and bone formation.

Main Results:

• Hormone replacement therapy (HRT) is the most researched preventive treatment for osteoporosis.
• Alternative treatments inhibiting bone resorption or stimulating bone formation are under investigation.
• Treating established osteoporosis is challenging, with methods having risks and unconfirmed fracture reduction benefits.

Conclusions:

• Osteoporosis is largely preventable, especially in women, offering potential for significant healthcare savings.
• HRT provides benefits beyond osteoporosis prevention for those who opt for it.
• Further research is needed to confirm the efficacy of new treatments and their impact on fracture incidence.